02172.HK
MicroPort NeuroTech Limited
HKSE · Healthcare · Medical - Devices · CN
HKD 8.06
+0.00%Year over year
Reported trailing growth
- Revenue
- +2.8%
- EBITDA
- +6.7%
- EBIT
- -9.7%
- EPS
- -25.6%
- Free cash flow
- -34.9%
- Operating cash flow
- -30.1%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +12.1%
- EBITDA
- +24.5%
- EBIT
- +29.6%
- Net income
- +11.1%
- EPS
- +11.4%
- Free cash flow
- -4.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Dec 1, 2025